Cytokine Gene Polymorphisms in Patients Infected With Hepatitis B Virus

OBJECTIVE:Cytokines play a key role in the regulation of the immune response. The maximal capacity of cytokine production varies among individuals and correlates with the polymorphism in the cytokine gene promoters. The aim of this study was to characterize gene polymorphism in patients with chronic hepatitis B virus (HBV) infection and to determine the different patterns in patient subgroups.METHODS:The study population consisted of 77 patients with chronic HBV infection (23 low-level HBV replicative carriers, 23 compensated high-level HBV replicative carriers, 21 decompensated liver transplant candidates, and 10 patients with documented hepatocellular carcinoma). The genetic profile of five cytokines was analyzed by polymerase chain reaction–sequence-specific primer (SSP), and subjects were genotyped as high or low producers of tumor necrosis factor-α and interleukin (IL)-6, and as high, intermediate, or low producers of transforming growth factor-β1, interferon (IFN)-γ, and IL-10 based on single nucleotide substitutions. The control group included 10 healthy individuals who recovered from HBV infection and 48 healthy controls.RESULTS:A highly statistically significant difference in the distribution of the IFN-γ gene polymorphism (at position +879) was observed between patients with chronic HBV infection and controls. The majority of the patients (65.2%) exhibited the potential to produce low levels of IFN-γ (A/A genotype) compared with 37.5% of the control group (p = 0.003). Healthy individuals who recovered from HBV infection had a similar distribution of IFN-γ gene polymorphism as the healthy controls. No statistically significant difference in IFN-γ production was found between patients with low- and high-level HBV replication and between compensated and decompensated patients. There was also no statistically significant difference in the genetic ability to produce tumor necrosis factor-α (at position −308), IL-6 (at position −174), IL-10 (at position −1082, −819, and −592), and transforming growth factor-β1 (at position +10 and +25).CONCLUSION:These findings suggest an association between the genetic ability to produce low levels of IFN-γ and the susceptibility to develop chronic HBV infection.

[1]  M. Farrar,et al.  The molecular cell biology of interferon-gamma and its receptor. , 1993, Annual review of immunology.

[2]  M J Koziel,et al.  Cytokines in Viral Hepatitis , 1999, Seminars in liver disease.

[3]  F. Chisari,et al.  To kill or to cure: options in host defense against viral infection. , 1996, Current opinion in immunology.

[4]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[5]  F. Chisari,et al.  Hepatitis B Virus RNA-Binding Proteins Associated with Cytokine-Induced Clearance of Viral RNA from the Liver of Transgenic Mice , 1999, Journal of Virology.

[6]  Tsunehiro Kobayashi,et al.  The Impact of Interferon Gamma Receptor Expression on the Mechanism of Escape From Host Immune Surveillance in Hepatocellular Carcinoma , 2000, Hepatology.

[7]  H. Thomas,et al.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[9]  A. Bertoletti,et al.  Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. , 1997, Gastroenterology.

[10]  F. Chisari,et al.  Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Vitiello,et al.  HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. , 1993, Journal of immunology.

[12]  M. Czaja,et al.  In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis , 1989, The Journal of cell biology.

[13]  Schneider,et al.  A tumour necrosis factor‐alpha (TNF‐α) promoter polymorphism is associated with chronic hepatitis B infection , 1998 .

[14]  A. Ohta,et al.  Indispensable Role for TNF-α and IFN-γ at the Effector Phase of Liver Injury Mediated by Th1 Cells Specific to Hepatitis B Virus Surface Antigen1 , 2000, The Journal of Immunology.

[15]  David M. Griffith,et al.  Infectious Disease Clinics of North America: Preface , 2002 .

[16]  F. Chisari,et al.  HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon‐γ , 1992 .

[17]  J. Lavine,et al.  Cytokine inhibition of the hepatitis B virus core promoter , 1996, Hepatology.

[18]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[19]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[20]  R. Tur-kaspa,et al.  Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity , 1992, Hepatology.

[21]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[22]  R. Beasley.  Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.

[23]  P. Whorwell,et al.  Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. , 1999, Tissue antigens.

[24]  F. Chisari,et al.  Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines , 2000, Journal of Virology.

[25]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[26]  R. Williams,et al.  Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. , 1997, The Journal of clinical investigation.

[27]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Moss,et al.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis , 1995, The Journal of experimental medicine.

[29]  Chun Xu,et al.  Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis , 1998, Journal of Neuroimmunology.

[30]  J. Bidwell,et al.  Human cytokine gene nucleotide sequence alignments, 1998. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[31]  R. H. Schloemer,et al.  Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene , 1991, Journal of virology.

[32]  A. Bertoletti,et al.  Predominant T‐helper 1 cytokine profile of hepatitis B virus nucleocapsid‐specific T cells in acute self‐limited hepatitis B , 1997, Hepatology.

[33]  J. Bidwell,et al.  Human cytokine gene nucleotide sequence alignments: supplement 1. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[34]  A. Hajeer,et al.  In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[35]  B. Moss,et al.  Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens , 1992, Journal of virology.

[36]  F. Chisari,et al.  Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.